We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

83 hedge funds and large institutions have $136M invested in Infinity Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

97% more capital invested

Capital invested by funds: $68.9M → $136M (+$66.9M)

51% more funds holding

Funds holding: 55 → 83 (+28)

7% less call options, than puts

Call options by funds: $1.66M | Put options by funds: $1.78M

Holders
83
Holders Change
+28
Holders Change %
+50.91%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
25
Reduced
9
Closed
9
Calls
$1.66M
Puts
$1.78M
Net Calls
-$124K
Net Calls Change
-$117K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$21.9M
2
Millennium Management
Millennium Management
New York
+$7.81M
3
ACM
AIGH Capital Management
Maryland
+$5.51M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.05M
5
TLP
Tri Locum Partners
New York
+$4.04M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$30.2M
2
OM
Opaleye Management
Massachusetts
-$6.72M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.6M
4
BBA
Baker Bros. Advisors
New York
-$1.11M
5
EI
EAM Investors
California
-$893K
Name Holding Trade Value Shares
Change 		Change in
Stake
HIIFS
26
Harel Insurance Investments & Financial Services
Israel
$863K +$267K +80,000 New
BL
27
Bleichroeder LP
New York
$808K – – –
Morgan Stanley
28
Morgan Stanley
New York
$763K +$728K +218,185 +1,223%
CSS
29
Cubist Systematic Strategies
Connecticut
$737K +$761K +228,250 New
Northern Trust
30
Northern Trust
Illinois
$686K +$180K +53,879 +34%
ECM
31
ExodusPoint Capital Management
New York
$602K +$622K +186,486 New
KAM
32
Knightsbridge Asset Management
California
$559K +$578K +173,110 New
HF
33
HRT Financial
New York
$487K +$504K +151,043 New
EWM
34
Evercore Wealth Management
New York
$462K – – –
QI
35
QS Investors
New York
$361K +$271K +81,149 +266%
JF
36
Jump Financial
Illinois
$336K +$347K +104,000 New
Goldman Sachs
37
Goldman Sachs
New York
$312K +$62.7K +18,785 +24%
Ameriprise
38
Ameriprise
Minnesota
$299K +$254K +76,200 +465%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$285K – – –
Russell Investments Group
40
Russell Investments Group
United Kingdom
$223K +$105K +31,457 +83%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$204K -$21.6K -6,467 -9%
VF
42
Virtu Financial
New York
$203K +$210K +62,984 New
IA
43
Insight Advisors
Pennsylvania
$188K +$189K +56,600 New
State Street
44
State Street
Massachusetts
$186K +$7.67K +2,300 +4%
Simplex Trading
45
Simplex Trading
Illinois
$178K +$162K +48,629 +722%
T. Rowe Price Associates
46
T. Rowe Price Associates
Maryland
$127K – – –
Jane Street
47
Jane Street
New York
$123K +$127K +38,198 New
Creative Planning
48
Creative Planning
Kansas
$121K +$124K +37,310 New
Wolverine Trading
49
Wolverine Trading
Illinois
$112K +$124K +37,247 New
TRCT
50
Tower Research Capital (TRC)
New York
$100K +$52.4K +15,701 +102%
1
2
3 4

INFI Hedge Fund Activity: Q1 2021 in Review

83 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2021, worth a combined $136M — up 97% from $68.9M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new INFI positions and 9 closed out — a net gain of 29 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $21.9M. The largest seller was BVF Inc, cutting an estimated $30.2M.

  • 83 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2021, up from 55 in Q4 2020.
  • Funds reported $136M of Infinity Pharmaceuticals, Inc. stock for Q1 2021, up 97% quarter-over-quarter.
  • 38 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2021 and 9 closed out, a net change of +29 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2021 was Consonance Capital Management, an estimated $21.9M added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q1 2021 was BVF Inc, an estimated $30.2M sold.

Based on aggregated 13F filings for Q1 2021.